J. Bénard

Roland Eils, Lars Kaderali, Gudrun Schleiermacher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. da Silva, J. Bénard, J. Teyssier, 1989, Cancer genetics and cytogenetics.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

F. Bertucci, D. Birnbaum, P. Finetti, 2008, Oncogene.

A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2

P. Bénit, C. Culmsee, K. Blomgren, 2010, Cell Death and Differentiation.

Molecular Detection of Early-Stage Laryngopharyngeal Squamous Cell Carcinomas

P. Hainaut, J. Soria, L. Mao, 2005, Clinical Cancer Research.

Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients

G. Lenoir, J. Bosq, F. Janot, 2003, British Journal of Cancer.

WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non‐MYCN‐amplified neuroblastoma

E. Ségal-Bendirdjian, J. Bénard, D. Valteau‐Couanet, 2016, Molecular oncology.

MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification

G. Lenoir, A. Bernheim, J. Bénard, 2002, The Journal of pathology.

Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.

P. Moretto, R. Ortega, J. Bénard, 1996, Cellular and molecular biology.

Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

T. Ha-Duong, J. Bénard, R. Farinotti, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors

F. Collin, F. Chibon, P. Lagarde, 2010, Genes, chromosomes & cancer.

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

J. Blay, F. Collin, R. Sciot, 2010, British Journal of Cancer.

Outcome Prediction of Children with Neuroblastoma using a Multigene Expression Signature, a Retrospective SIOPEN/COG/ GPOH Study

A. Naranjo, F. Speleman, J. Vandesompele, 2011 .

Netrin-1 acts as a survival factor for aggressive neuroblastoma

D. Cappellen, A. Nakagawara, A. Puisieux, 2009, The Journal of experimental medicine.

[p53 status and response to chemotherapy].

J. Ahomadégbé, J. Bénard, 2003, Bulletin du cancer.

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients.

L. Zitvogel, J. Bénard, D. Valteau‐Couanet, 2002, Blood.

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.

J. Bénard, E. Osinaga, D. Valteau‐Couanet, 2013, Clinical chemistry.

Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.

J. Ahomadégbé, G. Riou, J. Bénard, 1991, Biochemical pharmacology.

MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.

J. Bénard, M. Barrois, S. Léonce, 2003, The American journal of pathology.

Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination

J. Bénard, J. Chatal, Y. Jacques, 1994, International journal of cancer.

Pleiotropic over‐expression of multidrug‐resistance‐related genes is correlated to MYCN and max mRNA accumulation during tumour progression in the IGR‐N‐91 human neuroblastoma model

D. Cappellen, J. Bénard, J. Bénard, 1997, International journal of cancer.

In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.

G. Riou, J. Bénard, A. Gavoille, 1988, European journal of cancer & clinical oncology.

Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.

R. Clarke, T. Tursz, J. Bénard, 1994, Cancer research.

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

O. Delattre, G. Tonini, H. Caron, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant.

J. Bénard, P. Couillin, J. Teyssier, 1992, Cancer genetics and cytogenetics.

Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy

G. Vassal, J. Merlin, J. Bénard, 2002, Cancer Gene Therapy.

(cid:1) N -p73 (cid:1) Accumulates in Human Neuroblastic Tumors

M. Kaghad, D. Caput, U. Moll, 2002 .

Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.

J. Bénard, G. Ichim, P. Mehlen, 2010, The Journal of clinical investigation.

Optimization of culture conditions for activation and large‐scale expansion of human T lymphocytes for bispecific antibody‐directed cellular immunotherapy

J. Bénard, C. Lamers, G. Stoter, 1992, International journal of cancer.

Extensive molecular screening for hereditary non-polyposis colorectal cancer

J. Pignon, P. Rougier, J. Bénard, 2000, British Journal of Cancer.

Effects of 9-hydroxy ellipticine on in vitro transcription of Trypanosoma cruzi DNAs.

G. Riou, J. Bénard, 1977, Biochemical and biophysical research communications.

Detection of a 45-kilodalton antigen overexpressed in a cisplatin-resistant human ovarian carcinoma cell line.

J. Bidart, T. Voeltzel, J. Bénard, 1994, Hybridoma.

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.

P. Opolon, P. Validire, J. Bénard, 2011, Experimental cell research.

Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.

A. Bernheim, J. da Silva, J. Bénard, 2001, Medical and pediatric oncology.

Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.

A. Bernheim, J. Bénard, B. Spengler, 1999, Cancer genetics and cytogenetics.

Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma

J. Bénard, R. Meier, N. Gross, 2009, BMC Cancer.

- Induced Caspase-8 Activation and Apoptosis in Metastatic Neuroblasts

Annick, J. Bénard, N. Gross, 2008 .

Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-κB activity

G. Vassal, J. Bénard, A. Dürrbach, 2003, British Journal of Cancer.

[Micro-RNA and oncogenesis].

J. Bénard, S. Douc‐Rasy, J. Bénard, 2005, Bulletin du cancer.

Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.

O. Delattre, A. Harel-Bellan, J. Bénard, 2014, Journal of the National Cancer Institute.

[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis].

O. Delattre, J. Bénard, V. Combaret, 1998, Bulletin du cancer.